This inventor holds 1 USPTO granted patent. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Eileen Goldstein: Innovator in HCV Treatment
Introduction
Eileen Goldstein is a prominent inventor based in Millbrae, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Hepatitis C virus (HCV) infections. Her innovative work has the potential to impact many lives.
Latest Patents
Eileen Goldstein holds 1 patent for her invention titled "Benzisothiazoles useful for treating or preventing HCV infection." This patent relates to benzisothiazoles and pharmaceutical compositions that inhibit the replication and proliferation of the HCV virus. The invention also encompasses the use of these compounds to treat or prevent HCV infections, showcasing her commitment to advancing medical science.
Career Highlights
Goldstein is currently associated with Rigel Pharmaceuticals, Incorporated, where she continues to develop groundbreaking treatments. Her work at Rigel has positioned her as a key player in the pharmaceutical industry, contributing to the development of innovative therapies.
Collaborations
Eileen collaborates with talented professionals such as Hui Hong and Emily Stauffer. These partnerships enhance her research and development efforts, fostering an environment of innovation and creativity.
Conclusion
Eileen Goldstein's contributions to the field of HCV treatment through her innovative patents and collaborations highlight her role as a leading inventor. Her work not only advances medical research but also offers hope for those affected by HCV infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile